相关实验视频

Updated: Jan 8, 2026

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

纤维细胞生长因子受体1的概念化,针对纳米药物

Yilin Ma¹, Mengqin Guo², Yang Liu³

¹Program of Pharmacy, International School, Jinan University, Guangzhou 510632, Guangdong, China.

Exploration of targeted anti-tumor therapy

|December 22, 2025

概括

用纳米药物向纤维细胞生长因子受体1 (FGFR1) 提供了一种有希望的策略,以克服癌症中对免疫检查点抑制剂 (ICI) 的耐药性. 对于这种向治疗的临床转化,需要进一步优化.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
纳米医学是一种纳米医学.

背景情况:

纤维细胞生长因子受体1 (FGFR1) 与癌症进展有关,影响细胞增殖,存活和分化.
FGFR1信号传递有助于抵抗免疫检查点抑制剂 (ICI),如pembrolizumab和nivolumab.
向FGFR1提供了一种治疗途径,通过调节瘤微环境来增强ICI的疗效.

研究的目的:

探索使用与抗FGFR1抗体修饰的纳米药物向FGFR1-过度表达瘤的潜力.
评估抗FGFR1抗体结合纳米药物作为向癌症治疗策略的可行性.
确定挑战,并建议FGFR1向纳米医学临床应用的未来方向.

主要方法:

对FGFR1在癌症和ICI耐药性中的作用进行现有研究的审查.
用抗FGFR1抗体 (例如,OM-RCA-01) 进行纳米医药表面修饰的概念化,用于有针对性的输送.
对结合FGFR1抑制与ICI增强的潜在治疗策略的讨论.

主要成果:

FGFR1是癌症治疗和克服ICI耐药性的验证标.
抗FGFR1抗体修饰的纳米药物显示出针对高FGFR1瘤的向治疗的潜力.
临床应用在大规模生产质量控制方面面临挑战.

结论:

用抗FGFR1抗体修改纳米药物是针对性癌症治疗的可行策略.
进一步的研究和优化对于解决制造挑战和促进临床翻译至关重要.
这种方法可能会导致更有效和更具成本效益的瘤治疗选择.

关键词:

对抗FGFR1抗体的抗体针对癌症的向向.纤维细胞生长因子受体1 纳米医药是一种纳米医药.

更多相关视频

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Introduction to Fibroblasts

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Fibronectins Connect Cells with ECM

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...